CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
NCT ID: NCT01032044
Last Updated: 2016-04-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
164 participants
INTERVENTIONAL
2010-02-28
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is a randomized controlled outcomes study including patients already treated for Barrett's Esophagus lesion(s) and undergoing high definition white light endoscopy follow up procedure, with or without pCLE (2 arms will be considered in this study). The procedures will be carried out per standards of practice with appropriately trained physicians.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy
NCT00795184
Confocal Laser Endomicroscopy and Endoscopic Mucosal Resection
NCT01124994
Confocal Laser Endomicroscopy in Digestive Diseases
NCT01156064
Probe-based Volumetric Laser Endomicroscopy (pVLE) of Endoscopic Mucosal Resection (EMR) Tissue in Patients With Barrett's Dysplasia
NCT02366039
Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection
NCT02189226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard endoscopic evaluation
Standard high-definition white light endoscopy guided evaluation
Standard endoscopic evaluation
Treatment modalities can include endoscopic mucosal resection, radio-frequency ablation or photodynamic therapy
pCLE-guided evaluation
Endoscopic evaluation of BE guided by probe-based Confocal Laser Endomicroscopy (pCLE guided evaluation)
pCLE guided evaluation
Treatment modalities include endoscopic mucosal resection, radio-frequency ablation, or photodynamic therapy. probe-based Confocal Laser Endomicroscopy is used to decide on re-treatment or not, and to guide and evaluate the treatment during the same endoscopic procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard endoscopic evaluation
Treatment modalities can include endoscopic mucosal resection, radio-frequency ablation or photodynamic therapy
pCLE guided evaluation
Treatment modalities include endoscopic mucosal resection, radio-frequency ablation, or photodynamic therapy. probe-based Confocal Laser Endomicroscopy is used to decide on re-treatment or not, and to guide and evaluate the treatment during the same endoscopic procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing any type of endoscopic BE ablation treatment
* \<2cm of circumferential BE and \<5 total islands of BE on prior to last ablation.
* Age \> 18 years
* Ability to provide written, informed consent
Exclusion Criteria
* Circumferential BE
* Complete eradication of BE documented by biopsies
* Inability to obtain biopsies due to anticoagulation, varices, etc.
* Allergy to fluorescein
* Pregnancy
* Renal insufficiency
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cellvizio Inc.
INDUSTRY
Mauna Kea Technologies
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Wallace, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic Jacksonville, Florida, United States
Anne Osdoit
Role: STUDY_DIRECTOR
Mauna Kea Technologies, Paris, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Jacksonville, Florida, United States
University of Chicago Hospital
Chicago, Illinois, United States
Veterans Affairs Hospital
Kansas City, Missouri, United States
University of Washington Medical Center
Seattle, Washington, United States
Centre Hospitalier Universitaire
Nantes, , France
University College London Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wallace MB, Crook JE, Saunders M, Lovat L, Coron E, Waxman I, Sharma P, Hwang JH, Banks M, DePreville M, Galmiche JP, Konda V, Diehl NN, Wolfsen HC. Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett's esophagus. Gastrointest Endosc. 2012 Sep;76(3):539-47.e1. doi: 10.1016/j.gie.2012.05.004. Epub 2012 Jun 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MKT-2009-BE-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.